Search Results

Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment.

Baxter Announces U.S. FDA 510(k) Clearance of Homechoice Claria with Sharesource

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform.

An Inspiring Mentorship Experience

How volunteering in STEM makes a meaningful difference

Baxter to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 3rd Annual HealthCONx virtual conference via webcast on Tuesday, December 1, 2020. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 11:20 a.m. Eastern Time.  The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through May 30, 2021.

Baxter Publishes its First Sustainability Accounting Standards Board (SASB) Index and Celebrates Continued Inclusion in the Dow Jones Sustainability Indices (DJSI)

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today published its first Sustainability Accounting Standards Board (SASB) index, a voluntary public disclosure that provides transparent and relevant corporate responsibility information to investors and other key stakeholders.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock. The dividend is payable on January 4, 2021, to shareholders of record as of December 4, 2020. The indicated annual dividend rate is $0.98 per share of common stock.  About Baxter

Baxter Reports Third-Quarter 2020 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported earnings for the third quarter of 2020 and updated its outlook for full-year 2020. 

Baxter Announces Proposed $650 Million Senior Notes Offering

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that it proposes to offer, subject to market conditions and other factors, $650 million aggregate principal amount of senior notes due 2031 (the “Notes”).

On the Frontlines in Latin America with Save the Children

A closer look at how one of Baxter International Foundation’s partners, Save the Children, is taking a holistic approach to supporting communities throughout COVID-19’s epicenter  

Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of All Sigma Spectrum Infusion Pumps (V6, V8, and IQ)

Baxter International Inc. announced today it has issued an Urgent Device Correction to reinforce important safety information regarding cleaning practices of all Spectrum infusion pumps distributed in the United States, Canada, and the Caribbean, as deviations from the specified cleaning methods may impair infusion pump functionality and performance.